Gotham Holdings, LP v. Health Grades, Inc.

534 F. Supp. 2d 442, 2008 U.S. Dist. LEXIS 11568, 2008 WL 449689
CourtDistrict Court, S.D. New York
DecidedFebruary 15, 2008
Docket07 Civ. 2563(MGC)
StatusPublished
Cited by3 cases

This text of 534 F. Supp. 2d 442 (Gotham Holdings, LP v. Health Grades, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Gotham Holdings, LP v. Health Grades, Inc., 534 F. Supp. 2d 442, 2008 U.S. Dist. LEXIS 11568, 2008 WL 449689 (S.D.N.Y. 2008).

Opinion

MEMORANDUM OPINION

CEDARBAUM, District Judge.

Gotham Holdings, LP (“Gotham”), Pri-marius Partners LP, Primarius Offshore Partners Ltd., Primarius Focus LP, Pri-marius China Fund LP, Willow Creek Capital Partners, LP, Willow Creek Capital Partners II, LP, and Willow Creek Offshore, Ltd. sue Health Grades, Inc. (“Health Grades”) and Essex Woodlands Health Ventures (“Essex”) for securities fraud under § 10(b) of the Securities Exchange Act of 1934, Rule 10(b) — 5, and § 12(a)(2) of the Securities Act of 1938, and for common law fraud and negligent misrepresentation. Defendants’ Rule 12(b)(6) and Rule 9(b) motions to dismiss the § 10(b) claim were denied at oral argument as to Essex on October 11, 2007, and as to Health Grades on January 10, 2008. For the following reasons, the Rule 12(b)(6) motions to dismiss the § 12(a)(2) claim are granted; the motions to dismiss the common law fraud claim are denied; and the motions to dismiss the negligent misrepresentation claim are denied as premature.

BACKGROUND

Health Grades is a Delaware corporation in the business of “grading” and providing reports concerning hospitals, physicians, and other health care providers. Prior to December 19, 2005, Essex, a healthcare venture capital LLC registered in Delaware, owned approximately 9 million shares of Health Grades’ stock, almost 30% of the outstanding shares. Plaintiffs, a group of hedge funds operating primarily in the United States, 1 purchased various *444 numbers of shares of Health Grades from Essex in two separate offerings to institutional investors. Some principal officers of Health Grades assisted Essex in its sales efforts.

Plaintiffs allege that omissions and misrepresentations of information regarding the status of a lucrative contract between Health Grades and Hewitt Associates, Inc. (“Hewitt”), a human resources outsourcing and consulting company, induced their purchase. They claim that when the true information regarding the status of the Hewitt contract was disclosed, the price of Health Grades’ stock collapsed, leading to substantial losses for them.

DISCUSSION

Defendants move to dismiss the § 12(a)(2), negligent misrepresentation, and common law fraud claims for failure to state a claim pursuant to Rule 12(b)(6). “To survive dismissal, the plaintiff must provide the grounds upon which his claim rests through factual allegations sufficient ‘to raise a right to relief above the speculative level.’ ” ATSI Communications, Inc. v. Shaar Fund, Ltd., 493 F.3d 87, 98 (2d Cir.2007) (quoting Bell Atl. Corp. v. Twombly, — U.S. -, -, 127 S.Ct. 1955, 1965, 167 L.Ed.2d 929 (2007)).

I. § 12(a)(2) of the Securities Act of 1933, 15 U.S.C. § 77Z(a) (2)

Plaintiffs’ § 12(a)(2) claim fails because there is no evidence that defendants’ alleged misrepresentations or omissions were contained in or related to a prospectus. Section 12(a)(2) provides that “[a]ny person who ... offers or sells a security ... by means of a prospectus or oral communication, which includes an untrue statement of a material fact or omits to state a material fact ... shall be liable ... to the person purchasing such security from him ....” (emphasis added). A prospectus for purposes of § 12(a)(2) “is confined to documents related to public offerings by an issuer or its controlling shareholders.” Gustafson v. Alloyd Co. Inc., 513 U.S. 561, 569, 115 S.Ct. 1061, 131 L.Ed.2d 1 (1995). “[T]he phrase, ‘oral communication’ is restricted to oral communications that relate to a prospectus.” Id. at 567-68, 115 S.Ct. 1061. According to the Supreme Court in Gustafson:

The primary innovation of the 1933 Act was the creation of federal duties — for the most part, registration and disclosure obligations — in connection with public offerings .... We are reluctant to conclude that § 12[ (a) ] (2) creates vast additional liabilities that are quite independent of the new substantive obligations the Act imposes. It is more reasonable to interpret the liability provisions of the 1933 Act as designed for the primary purpose of providing remedies for violations of the obligations it had created.

Id. at 571-72, 115 S.Ct. 1061 (citations omitted). Thus, an essential element of the § 12(a)(2) claim is that the omissions or misrepresentations being sued upon are either contained in or relate directly to a prospectus. Id. at 581, 115 S.Ct. 1061; Yung v. Lee, 432 F.3d 142, 147 (2d Cir. 2005).

Plaintiffs allege that Essex’s sales were made pursuant to Health Grades’ prospectus. But the misrepresentations on which plaintiffs sue are not contained in the prospectus or in oral statements about the prospectus. In their letter to the court dated January 18, 2008, plaintiffs concede that the prospectus does not include any false statements or material omissions, but argue that the “numerous oral communications with plaintiff ... related to the sale of Essex stock, and hence to the prospectus pursuant to which that stock was being sold.” This link to the prospectus is outside the scope of the § 12(a)(2) claim. The oral communications *445 were about the status of the Hewitt contract, not about the prospectus itself. That the stock was allegedly being sold “pursuant to” a previous Health Grades prospectus is irrelevant. Since the alleged false statements were not directly related to the prospectus, there can be no claim under § 12(a)(2).

Indeed, there are no allegations that Essex was even under an obligation to issue a prospectus in connection with its sales of Health Grades stock. The sales offers were made to institutional investors, not the public at large, and the transactions were private ones in the secondary market. Liability under § 12(a)(2) attaches only if Essex was under an obligation to distribute a prospectus in selling its shares. Gustafson, 513 U.S. at 571, 115 S.Ct. 1061 (“the liability imposed by § 12[ (a) ] (2) cannot attach unless there is an obligation to distribute the prospectus in the first place”); Yung, 432 F.3d at 149 (“[A] Section 12(a)(2) action cannot be maintained by a plaintiff who acquires securities through a private transaction, whether primary or secondary.... [T]here is no ‘obligation’ to distribute a document that describes a public offering to a private purchaser.”). As in Yung, the fact that Health Grades’ prospectus was included in the sales offering documents made available to purchasers is irrelevant. 432 F.3d at 149. Plaintiffs have not alleged that Essex was under any obligation to issue a prospectus for the sales at issue. Thus, Essex’s sales do not qualify for liability under § 12(a)(2) of the Securities Act.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anegada Master Fund, Ltd. v. PXRE Group Ltd.
680 F. Supp. 2d 616 (S.D. New York, 2010)
Luminent Mortgage Capital, Inc. v. Merrill Lynch & Co.
652 F. Supp. 2d 576 (E.D. Pennsylvania, 2009)
380544 CANADA, INC. v. Aspen Technology, Inc.
633 F. Supp. 2d 15 (S.D. New York, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
534 F. Supp. 2d 442, 2008 U.S. Dist. LEXIS 11568, 2008 WL 449689, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gotham-holdings-lp-v-health-grades-inc-nysd-2008.